SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001045969-03-000693
Filing Date
2003-03-21
Accepted
2003-03-21 14:01:57
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.txt 10-K 411989
3 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 639
4 CONSENT OF KPMG LLP dex231.txt EX-23.1 2006
5 SECTION 906 CEO AND CFO CERTIFICATION dex991.txt EX-99.1 1783
  Complete submission text file 0001045969-03-000693.txt   418513
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20945 | Film No.: 03612056
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10